HUTCHMED (China) (HCM) Research & Development: 2016-2025
Historic Research & Development for HUTCHMED (China) (HCM) over the last 4 years, with Jun 2025 value amounting to -$209.6 million.
- HUTCHMED (China)'s Research & Development rose 11.90% to -$209.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$139.8 million, marking a year-over-year decrease of 174.34%. This contributed to the annual value of $212.1 million for FY2024, which is 29.77% down from last year.
- HUTCHMED (China)'s Research & Development amounted to -$209.6 million in Q2 2025, which was down 236.13% from $154.0 million recorded in Q4 2024.
- HUTCHMED (China)'s 5-year Research & Development high stood at $156.1 million for Q4 2022, and its period low was -$237.9 million during Q2 2024.
- Its 3-year average for Research & Development is -$35.0 million, with a median of -$27.9 million in 2023.
- Over the last 5 years, HUTCHMED (China)'s Research & Development had its largest YoY gain of 355.95% in 2021, and its largest YoY loss of 456.10% in 2021.
- HUTCHMED (China)'s Research & Development (Quarterly) stood at $116.1 million in 2021, then surged by 34.44% to $156.1 million in 2022, then declined by 1.54% to $153.7 million in 2023, then increased by 0.16% to $154.0 million in 2024, then climbed by 11.90% to -$209.6 million in 2025.
- Its Research & Development was -$209.6 million in Q2 2025, compared to $154.0 million in Q4 2024 and -$237.9 million in Q2 2024.